InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-2.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Lorrain Daniel S., Chief Scientific Officer. Officer active across 1 company, notably Contineum Therapeutics, Inc.. In total, 15 filings have been recorded. Split: 0 buy · 13 sells. Total volume traded: €568k. History available since 18 November 2024. The latest transaction was filed on 1 June 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations15 total
4,170 shares@ US$13.15640.011% mcap8.2% of flowClass A Common StockSEC:0001628280-26-039641:0
3,870 shares@ US$13.060.010% mcap10.3% of flowClass A Common StockSEC:0001628280-26-029435
3,870 shares@ US$13.060.010% mcap10.3% of flowClass A Common StockSEC:0001628280-26-029435:0
4,170 shares@ US$13.43260.011% mcap11.6% of flowClass A Common StockSEC:0001628280-26-023949
4,170 shares@ US$13.43260.011% mcap11.6% of flowClass A Common StockSEC:0001628280-26-023949:0
4,300 shares@ US$1.010.9% of flowClass A Common StockSEC:0001437749-26-005889
4,300 shares@ US$1.010.0009% mcap0.9% of flowClass A Common StockSEC:0001437749-26-005889:0
3,000 shares@ US$14.82299.0% of flowClass A Common StockSEC:0001437749-26-003212
3,000 shares@ US$14.82290.0088% mcap9.0% of flowClass A Common StockSEC:0001437749-26-003212:0
3,670 shares@ US$10.34837.8% of flowClass A Common StockSEC:0001437749-26-000616
3,670 shares@ US$10.34830.0076% mcap7.8% of flowClass A Common StockSEC:0001437749-26-000616:0
4,170 shares@ US$12.232410.4% of flowClass A Common StockSEC:0001437749-25-038936
4,170 shares@ US$12.23240.010% mcap10.4% of flowClass A Common StockSEC:0001437749-25-038936:0
1,010 shares@ US$16.01722.7% of flowClass A Common StockSEC:0001437749-24-036349:0
6,091 shares@ US$16.373816.5% of flowClass A Common StockSEC:0001437749-24-035887:0
15 of 15 declarations
About Lorrain Daniel S.
Lorrain Daniel S. serves as Chief Scientific Officer at Contineum Therapeutics, Inc. In this role, he oversees the company's research and development activities. His expertise in biological sciences enables him to lead innovation projects and ensure product quality. Daniel plays a key role in implementing research and development strategies.
